People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment prolongs survival.

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

Galleri blood test detects fifty cancers early via cfDNA analysis for adults 50+ with no symptoms, though not a standard ...

The study investigators identified 24 prospective trials with 2,850 patients. The median patient age ranged between 59 and 77 years. Overall, testosterone recovery, defined at 240 ng/dL, was observed ...

(UroToday.com) The 2025 AUA annual meeting featured a prostate cancer session and a presentation by Dr. Madison Krischak discussing access to prostate cancer clinical trials in the VA and whether ...